Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?

Semin Dial. 2007 Jan-Feb;20(1):24-32. doi: 10.1111/j.1525-139X.2007.00234.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Calcium / blood
  • Calcium, Dietary / administration & dosage
  • Chronic Disease
  • Humans
  • Hyperparathyroidism, Secondary / drug therapy*
  • Kidney Diseases / complications*
  • Parathyroid Hormone / blood
  • Phosphates / blood
  • Practice Guidelines as Topic
  • Receptors, Calcitriol / agonists

Substances

  • Bone Density Conservation Agents
  • Calcium, Dietary
  • Parathyroid Hormone
  • Phosphates
  • Receptors, Calcitriol
  • Calcium